DRRX
Price
$1.94
Change
-$0.01 (-0.52%)
Updated
Aug 29, 03:55 PM (EDT)
Capitalization
60.25M
ZOMDF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
40.28M
Interact to see
Advertisement

DRRX vs ZOMDF

Header iconDRRX vs ZOMDF Comparison
Open Charts DRRX vs ZOMDFBanner chart's image
DURECT
Price$1.94
Change-$0.01 (-0.52%)
Volume$100
Capitalization60.25M
Zomedica
Price$0.04
Change-$0.00 (-0.00%)
Volume$1.04M
Capitalization40.28M
DRRX vs ZOMDF Comparison Chart in %
Loading...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZOMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRRX vs. ZOMDF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRRX is a Buy and ZOMDF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (DRRX: $1.94 vs. ZOMDF: $0.04)
Brand notoriety: DRRX and ZOMDF are both not notable
DRRX represents the Pharmaceuticals: Generic, while ZOMDF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: DRRX: 25% vs. ZOMDF: 92%
Market capitalization -- DRRX: $60.25M vs. ZOMDF: $40.28M
DRRX [@Pharmaceuticals: Generic] is valued at $60.25M. ZOMDF’s [@Medical/Nursing Services] market capitalization is $40.28M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRRX’s FA Score shows that 0 FA rating(s) are green whileZOMDF’s FA Score has 1 green FA rating(s).

  • DRRX’s FA Score: 0 green, 5 red.
  • ZOMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, ZOMDF is a better buy in the long-term than DRRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRRX’s TA Score shows that 5 TA indicator(s) are bullish while ZOMDF’s TA Score has 5 bullish TA indicator(s).

  • DRRX’s TA Score: 5 bullish, 6 bearish.
  • ZOMDF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ZOMDF is a better buy in the short-term than DRRX.

Price Growth

DRRX (@Pharmaceuticals: Generic) experienced а +2.11% price change this week, while ZOMDF (@Medical/Nursing Services) price change was +0.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.48%. For the same industry, the average monthly price growth was +6.46%, and the average quarterly price growth was +9.89%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Medical/Nursing Services (+0.48% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRRX($60.2M) has a higher market cap than ZOMDF($40.3M). DRRX YTD gains are higher at: 158.667 vs. ZOMDF (-65.750). DRRX has higher annual earnings (EBITDA): -15.23M vs. ZOMDF (-36.65M). ZOMDF has more cash in the bank: 58.1M vs. DRRX (6.5M). DRRX has less debt than ZOMDF: DRRX (1.75M) vs ZOMDF (2.52M). ZOMDF has higher revenues than DRRX: ZOMDF (28.4M) vs DRRX (1.66M).
DRRXZOMDFDRRX / ZOMDF
Capitalization60.2M40.3M149%
EBITDA-15.23M-36.65M42%
Gain YTD158.667-65.750-241%
P/E RatioN/AN/A-
Revenue1.66M28.4M6%
Total Cash6.5M58.1M11%
Total Debt1.75M2.52M69%
FUNDAMENTALS RATINGS
DRRX vs ZOMDF: Fundamental Ratings
DRRX
ZOMDF
OUTLOOK RATING
1..100
185
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZOMDF's Valuation (29) in the Pharmaceuticals Major industry is somewhat better than the same rating for DRRX (71) in the Pharmaceuticals Other industry. This means that ZOMDF’s stock grew somewhat faster than DRRX’s over the last 12 months.

ZOMDF's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as DRRX (100) in the Pharmaceuticals Other industry. This means that ZOMDF’s stock grew similarly to DRRX’s over the last 12 months.

ZOMDF's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as DRRX (100) in the Pharmaceuticals Other industry. This means that ZOMDF’s stock grew similarly to DRRX’s over the last 12 months.

DRRX's Price Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as ZOMDF (65) in the Pharmaceuticals Major industry. This means that DRRX’s stock grew similarly to ZOMDF’s over the last 12 months.

DRRX's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ZOMDF (100) in the Pharmaceuticals Major industry. This means that DRRX’s stock grew similarly to ZOMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRRXZOMDF
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZOMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRPTF19.28N/A
N/A
Getlink SE
PRKWF3.37N/A
N/A
Parkway Life REIT
PROM1.20N/A
N/A
Propel Media, Inc.
IVAUF11.01N/A
N/A
Investcorp AI Acquisition Corp.
KSTOF2.35N/A
N/A
KISTOS HOLDINGS PLC

DRRX and

Correlation & Price change

A.I.dvisor tells us that DRRX and UPC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRRX and UPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
+0.52%
UPC - DRRX
27%
Poorly correlated
-3.53%
SNDL - DRRX
24%
Poorly correlated
+6.32%
OGI - DRRX
22%
Poorly correlated
+3.59%
ACB - DRRX
22%
Poorly correlated
+5.44%
ZOMDF - DRRX
22%
Poorly correlated
+0.24%
More

ZOMDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZOMDF has been loosely correlated with SNDL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ZOMDF jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZOMDF
1D Price
Change %
ZOMDF100%
+0.24%
SNDL - ZOMDF
38%
Loosely correlated
+6.32%
CDNA - ZOMDF
30%
Poorly correlated
-1.35%
EBS - ZOMDF
29%
Poorly correlated
-2.33%
ARAY - ZOMDF
29%
Poorly correlated
-0.64%
BNR - ZOMDF
28%
Poorly correlated
-2.70%
More